Adequacy of surveillance to detect endemic rubella transmission in the United States

Clinical Infectious Diseases

Volumn 43, Issue SUPPL. 3, 2006, Pages

  Averhoff, Francisco ^a   Zucker, Jane ^e   Vellozzi, Claudia ^b   Redd, Susan ^c   Woodfill, Celia ^f   Waterman, Steve ^d   Baggs, James ^b   Weinberg, Michelle ^d   Rodriquez Lainz, Alfonso ^f   Carrion, Veronica ^h   Goto, Collin ^g   Reef, Susan E ^c  

^a NATIONAL CENTER FOR PREPAREDNESS DETECTION AND CONTROL OF INFECTIOUS DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^d NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^e New York City Department of Health   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g RADY CHILDREN'S HOSPITAL   (United States)

^h Mexico Direccion General de Epidemiologia   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CITY; DATA ANALYSIS; ENDEMIC DISEASE; EPIDEMIC; HEALTH CARE SYSTEM; HEALTH MAINTENANCE ORGANIZATION; HEALTH SURVEY; HUMAN; INFECTION CONTROL; LABORATORY; MEASLES; MEXICO; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RUBELLA; UNITED STATES; VALIDATION STUDY; VIRUS TRANSMISSION;

DISEASE NOTIFICATION; DISEASE OUTBREAKS; HUMANS; NATIONAL HEALTH PROGRAMS; POPULATION SURVEILLANCE; RUBELLA; UNITED STATES;

EID: 33750341045     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/505948     Document Type: Article

References (12)

1. Reef SE, Redd SB, Abernathy E, Zimmerman L, Icenogle JP. The epidemiological profile of rubella and congenital rubella syndrome in the United States, 1998-2004: the evidence for absence of endemic transmission. Clin Infect Dis 2006; 43(Suppl 3):S126-32 (in this supplement).
2. Roush S, Birkhead G, Koo D, et al. Mandatory reporting of diseases and conditions by healthcare professionals and laboratories. JAMA 1999; 282:164-70.
3. Centers for Disease Control and Prevention. Case definitions for infectious conditions under public health surveillance. MMWR Recomm Rep 1997; 46(RR-10):1-55.
4. Harpaz R, Papania M, Fujii K, et al. Lessons learned from establishing and evaluating indicators of the quality of measles surveillance in the United States, 1996 1998. J Infect Dis 2004; 189(Suppl 1):S196-203.
5. Reef S, Frey T, Theall K, et al. The changing epidemiology of rubella in the 1990s. JAMA 2002; 287:464-72.
6. Weinberg M, Waterman S, Alvarez Lucas C, et al. The U.S.-Mexico border infectious disease surveillance project: establishing bi-national border surveillance. Emerg Infect Dis 2003; 9:97-102.
7. Chen R, DeStefano F, Davis R, et al. The vaccine safety datalink: immunization research in health maintenance organizations in the USA. Bull World Health Organ 2000; 78:186-94.
8. Harpaz R, Papania M, McCauley M, et al. Has surveillance been adequate to detect endemic measles surveillance in the United States? J Infect Dis 2004; 189(Suppl 1):S191-5.
9. Papania M, Strebel P. Measles surveillance: the importance of finding the tip of the iceberg [letter]. Lancet 2005; 365:100-1.
10. Katz S, Hinman A. Summary and conclusions: measles elimination meeting, 16-17 March 2000. J Infect Dis 2004; 189(Suppl 1):S43-7.
11. American Academy of Pediatrics. Rubella. In: 2003 red book: report of the Committee on Infectious Diseases, 26th ed. Elk Grove Village, IL: American Academy of Pediatrics, 2003; 536-41.
12. Schrag S, Fiore A, Gonik B, et al. Vaccination and perinatal prevention practices among obstetrician-gynecologists. Obstet Gynecol 2003; 101: 704-10.